Virtus LifeSci Biotech Products ETF
14 hedge funds and large institutions have $3.89M invested in Virtus LifeSci Biotech Products ETF in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.24M | |
| 2 | +$266K | |
| 3 | +$213K | |
| 4 |
Morgan Stanley
New York
|
+$25.3K |
| 5 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$13.6K |
Top Sellers
| 1 | -$1.28M | |
| 2 | -$80.7K | |
| 3 | -$43.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$27.7K |
| 5 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$9K |